Bacterial nanocellulose: The future of controlled drug delivery?
Poetzinger Y, Kralisch D, Fischer D (2017)
Publication Type: Journal article
Publication year: 2017
Journal
Book Volume: 8
Pages Range: 753-761
Journal Issue: 9
Abstract
Although bacterial nanocellulose (BNC), a natural nanostructured biopolymer network, offers unique material characteristics, the number of drug-loaded BNC-based carriers in clinical trials or on the market is still low. This report provides an overview of aspects still limiting the broad application of BNC as drug-delivery system and the challenges for its future applications. Continuous large-scale production, storability, the loading and controlled release of critical drugs, for example, with high molar mass or highly lipophilic character as well as the formulation of long-term release systems will be highlighted. Recent achievements toward promoting the application of BNC as drug-delivery system and overcoming these obstacles will be discussed.
Authors with CRIS profile
Involved external institutions
Germany (DE)How to cite
APA:
Poetzinger, Y., Kralisch, D., & Fischer, D. (2017). Bacterial nanocellulose: The future of controlled drug delivery? Therapeutic Delivery, 8(9), 753-761. https://dx.doi.org/10.4155/tde-2017-0059
MLA:
Poetzinger, Yvette, Dana Kralisch, and Dagmar Fischer. "Bacterial nanocellulose: The future of controlled drug delivery?" Therapeutic Delivery 8.9 (2017): 753-761.
BibTeX: Download